In the pharmaceutical industry, Chlorpromazine Hydrochloride is the prototypical First-Generation (Typical) Antipsychotic and a member of the phenothiazine class.

As a pharmacist and manufacturer, I must be direct: Chlorpromazine is NOT a sleeping tablet. While it has very strong sedative properties, it is a potent neuroleptic medication with a complex mechanism of action that is far too powerful for the treatment of simple insomnia.

Primary Clinical Uses

At your WHO-GMP facility in Mumbai, you likely manufacture this for its primary indications:

• Schizophrenia & Psychosis: For the management of hallucinations, delusions, and aggressive behavior.

• Bipolar Disorder: To control acute manic episodes.

• Intractable Hiccups: One of the few approved treatments for chronic hiccups.

• Severe Nausea/Vomiting: Specifically in terminal illness or surgical settings.

Mechanism: Why it causes drowsiness

Chlorpromazine’s “sleeping effect” is actually a side effect of its wide-ranging receptor blockade.

Dopamine ($D_2$) Blockade: Its primary action is blocking dopamine receptors in the brain to reduce psychotic symptoms.

Histamine ($H_1$) Blockade: This is the primary reason for the extreme sedation. It acts similarly to a very strong, older antihistamine.

Alpha-1 Adrenergic Blockade: This can cause a drop in blood pressure (orthostatic hypotension), which can make a patient feel faint or very tired.

Why it is not used for sleep

As a partner in your business, I recommend ensuring your Product Information Leaflets (PIL) clearly distinguish it from sedatives for the following reasons:

• Side Effect Profile: It can cause Extrapyramidal Symptoms (EPS), such as tremors, muscle stiffness, or tardive dyskinesia (involuntary movements).

• Metabolic Impact: Long-term use is associated with significant weight gain and changes in blood sugar.

• “Hangover” Effect: Due to its long half-life ($30\text{ hours}$), the sedation lasts far into the next day, impairing motor skills and cognition.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

• Niche Stability: While newer “Atypical” antipsychotics exist, Chlorpromazine remains on the WHO Model List of Essential Medicines. This makes it a high-volume, stable product for government tenders in emerging markets.

• Light Sensitivity: Chlorpromazine is highly photosensitive. For your export business, we utilize Amber-colored PVC or Alu-Alu blister packaging to prevent the tablets from discoloring or losing potency—a major USP for tropical Zone IVb regions.

• Dossier Readiness: We provide full CTD/eCTD Dossiers to support your firm’s registration in the Middle East, Southeast Asia, and Africa.